JPS6165875A - Production of 1,5-benzothiazepine derivative - Google Patents
Production of 1,5-benzothiazepine derivativeInfo
- Publication number
- JPS6165875A JPS6165875A JP18543484A JP18543484A JPS6165875A JP S6165875 A JPS6165875 A JP S6165875A JP 18543484 A JP18543484 A JP 18543484A JP 18543484 A JP18543484 A JP 18543484A JP S6165875 A JPS6165875 A JP S6165875A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- hydroxy
- compound
- ester
- acetic ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は冠血管拡張作用を有する優れた医薬化合物、塩
酸ジルチアゼムの重要な中間体であるi般4I)(式中
、Mは低級フルコキシ基で置換されたフェニル基を表わ
す)
で示される1、5−ベンゾチアゼピン誘導体の新規製法
に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention discloses an important intermediate of diltiazem hydrochloride, an excellent pharmaceutical compound having coronary vasodilatory action, (I) (in the formula, M represents a phenyl group substituted with a lower flukoxy group). The present invention relates to a new method for producing a 1,5-benzothiazepine derivative represented by:
2−7ミノチオフエノールと一般志n>(式中、kは前
記と同じ基を表わし、Rはエステル残基を表わす)
で示されるグリシド酸エステルの縮合により容易に得ら
れる一般(式中、Arは前記と同じ基を表わす)で示さ
れる2−ヒドロキシ−3−(2−7ミノフエニルチオ)
−3−フェニルプロピオン酸より、−挙に化n I)を
製造する方法としては特開昭57−136581号が知
られているが、この方法では化合物(2)を一旦アルカ
リ塩とし、その後酸無水物を反応させる。2-7 Minothiophenol and the general formula n> (wherein k represents the same group as above and R represents an ester residue) 2-hydroxy-3-(2-7minophenylthio) represented by (Ar represents the same group as above)
JP-A-57-136581 is known as a method for producing compound (I) from -3-phenylpropionic acid, but in this method, compound (2) is first converted into an alkali salt, and then the React the anhydride.
本発明者らは、化合物(2)から化合物(I)を製造す
る更に優れた方法を開発した。本発明の方法によれば、
化合物ω0をあらかじめ塩を形成することなく、簡単な
操作で高純度の化合物(I)を従来より高収率で得るこ
とができる。すなわち、化合物ω1)、酢酸の活性エス
テルおよび塩基を適当な溶媒中に加え、加熱するだけで
目的の化合物(I)を与える。The present inventors have developed a more excellent method for producing compound (I) from compound (2). According to the method of the invention,
Compound (I) of high purity can be obtained in a higher yield than conventionally by simple operations without forming a salt of compound ω0 in advance. That is, the desired compound (I) is obtained by simply adding compound ω1), an active ester of acetic acid, and a base into a suitable solvent and heating.
用いる酢酸の活性エステルとしては、ペンタクロロフェ
ニルアセテート、p−ニトロフェニルアセテートの如き
電子吸引性の置換基を有するフェノール類の酢酸エステ
ル、N−ヒドロキシスクシンイミド−〇−アセテートや
N−ヒドロキシフタルイミド−〇−アセテートの如きN
−ヒドロキシ化合物のアセテートなどが使用できる。塩
基としては、トリエチルアミン、ピリジノ等通常の塩基
を用いることができ、反応溶媒としては特に反応に悪影
響を与えないものであれば制限はないが、例えばアセト
ニトリル、凡N−ジメチルホルムアミド、アセトンなど
が挙げられ、また反応に直接関与するとリジンや三級ア
ミンをそのまま溶媒として用いてもよい。The active esters of acetic acid used include acetic acid esters of phenols having electron-withdrawing substituents such as pentachlorophenylacetate and p-nitrophenyl acetate, N-hydroxysuccinimide-〇-acetate and N-hydroxyphthalimide-〇-acetate. N like
-Acetates of hydroxy compounds can be used. As the base, ordinary bases such as triethylamine and pyridino can be used, and as the reaction solvent, there is no particular restriction as long as it does not adversely affect the reaction, but examples include acetonitrile, N-dimethylformamide, acetone, etc. Lysine or tertiary amine may be used directly as a solvent if it directly participates in the reaction.
反応後は反応溶媒が水と混じるものであればそのまま水
中にあけ、アルカリ水溶液でフェノール残基を除いて得
た結晶を戸数するだけで化合物(I)が単離できる。反
応溶媒が水と混じらない場合は、溶媒を留去後同じ操作
をするか、溶媒抽出で目的物を得ることができる。After the reaction, if the reaction solvent is miscible with water, the compound (I) can be isolated by simply pouring it into water, removing the phenol residue with an aqueous alkali solution, and dividing the resulting crystals. If the reaction solvent is immiscible with water, the desired product can be obtained by performing the same operation after distilling off the solvent or by solvent extraction.
以下に実施例を挙げて具体的に説明する。This will be specifically explained below by giving examples.
実施例1
スレオ型々−2−ヒドロキシ−3−(2−7ミノフエニ
ルチオ)−3−(4−メトキシフェニル)フロピオン酸
1.276 g、ペンタクロロフェニルアセテ−)2.
59g、 ピリジン0.32g、およびトリエチルア
ミン0.4gをアセトニトリル12−中に加え6時間加
熱還流した。Example 1 1.276 g of threo-2-hydroxy-3-(2-7minophenylthio)-3-(4-methoxyphenyl)furopionic acid, pentachlorophenylacetate)2.
59 g of pyridine, 0.32 g of pyridine, and 0.4 g of triethylamine were added to 12-g of acetonitrile and heated under reflux for 6 hours.
冷却後アセトニトリルを留去し、残渣を炭酸すHラム1
.7gを水フェニル)−3−7セトキシー2.3−ジヒ
ドロ−1,5−ベンゾチアゼピン−4(5H)−オンの
標品のそれと一致した。After cooling, acetonitrile is distilled off and the residue is carbonated using H ram 1.
.. 7 g was matched with that of a standard of water phenyl)-3-7setoxy2,3-dihydro-1,5-benzothiazepin-4(5H)-one.
m、p、 195〜198°C
実施例2
スレオ型d/−2−ヒドロキシ−3−(2−7ミノフエ
ニルチオ)−3−(4−メトキシフェニル)フロピオン
酸1.276g、ペンタクロロフェニルアセテート2.
591gおよびピリジン2.56gを7セトニトリシー
2.3−ジヒドロ−1,5−ベンゾチアゼピン−4(5
H)−オンを得た。m, p, 195-198°C Example 2 Threo-type d/-2-hydroxy-3-(2-7minophenylthio)-3-(4-methoxyphenyl)furopionic acid 1.276 g, pentachlorophenylacetate 2.
591 g and 2.56 g of pyridine were dissolved in 7cetonitroxy 2,3-dihydro-1,5-benzothiazepine-4 (5
H)-one was obtained.
m、p、 197〜199°C
実施例3
スレオ型dz−2−ヒドロキシ−3−(2−7ミノフエ
ニルチオ)−3−(4−メトキシフェニル)プロピオン
e 1.276 g% p−ニトロフェニルアセテート
1.52 g 、 ピリジン0.64gおよびトリエチ
ルアミン0.2gをN、N−ジメチルホルムアミド12
m1に加え、100°Cで6時間攪拌した。冷却後炭酸
ナトリウム1.7gの水10−溶液中に3−アセトキシ
−2,3−ジヒドロ−1,5−ベンゾチアゼピン−4(
5H)−オンの結晶1.13gを得た。m, p, 197-199°C Example 3 Threo-type dz-2-hydroxy-3-(2-7minophenylthio)-3-(4-methoxyphenyl)propion e 1.276 g% p-nitrophenyl acetate 1 .52 g, 0.64 g of pyridine and 0.2 g of triethylamine were dissolved in N,N-dimethylformamide 12
ml and stirred at 100°C for 6 hours. After cooling, 3-acetoxy-2,3-dihydro-1,5-benzothiazepine-4 (
1.13 g of crystals of 5H)-one were obtained.
m、p、 195〜199°C
実施例4
d−2−ヒドロキシ−3−(2−アミノフェニルチオ)
−3−(4−メト午シフェニJv)プロピオン酸1.2
76 g、アセトン12−j、ペンタクロロフェニルア
セテート2.59g、)リエチルアミン0.4g及びピ
リジン0.32gを混合し、7.5時間加熱還流した。m, p, 195-199°C Example 4 d-2-hydroxy-3-(2-aminophenylthio)
-3-(4-methoxypheni Jv) propionic acid 1.2
76 g, acetone 12-j, pentachlorophenylacetate 2.59 g, ) ethylamine 0.4 g, and pyridine 0.32 g were mixed and heated under reflux for 7.5 hours.
以下実施fN3と同様に処理して1.30gのd−2−
(4−メトキシフェニル)−3−アセトキシ−2,3−
ジヒドロ−1,5−ベンゾチアゼピン−4(5H)−オ
ンを得た。Hereafter, 1.30 g of d-2-
(4-methoxyphenyl)-3-acetoxy-2,3-
Dihydro-1,5-benzothiazepin-4(5H)-one was obtained.
m、p、 145〜148°C
実施例5
d−2−ヒドロキシ−3−(2−アミノフェニルチオ)
−3−(4−メトキシフェニル)プロピオン酸1.27
6 g、 DMF 1217゜p−ニトロフェニルアセ
テート1.52g及びピリジン0.64 gを混合し、
5時間加熱還流した。以下実施例3と同様に処理して1
.23gのd−2−(4−メトキシフェニル)−3−ア
セトキシ−2,3−ジヒドロ−1,5−ベンゾチアゼピ
ン−4(5H)−オンを得り。m, p, 145-148°C Example 5 d-2-hydroxy-3-(2-aminophenylthio)
-3-(4-methoxyphenyl)propionic acid 1.27
6 g, DMF 1217゜ p-nitrophenyl acetate 1.52 g and pyridine 0.64 g were mixed;
The mixture was heated under reflux for 5 hours. The following treatment was carried out in the same manner as in Example 3.
.. 23 g of d-2-(4-methoxyphenyl)-3-acetoxy-2,3-dihydro-1,5-benzothiazepin-4(5H)-one were obtained.
m、p、 144〜147°C
実施例6
d−2−ヒドロキシ−3−(2−7ミノフエニルチオ)
−3−(4−メトキシフェニル)プロピオンl11.2
76g%p−二トロフェニルアセテート1.52g及び
ピリジン20mを混合し、5時間加熱還流した。以下実
施例3と同様に処理して1.21gのd−2−(4−メ
トキシフェニ)L/)−3−アセトキシ−2,3−ジヒ
ドロ−1,5−ベンゾチアゼピン〜4(5H)−オンを
得た。m, p, 144-147°C Example 6 d-2-hydroxy-3-(2-7minophenylthio)
-3-(4-methoxyphenyl)propion l11.2
1.52 g of 76g% p-nitrophenyl acetate and 20 m of pyridine were mixed and heated under reflux for 5 hours. Thereafter, 1.21 g of d-2-(4-methoxypheny)L/)-3-acetoxy-2,3-dihydro-1,5-benzothiazepine to 4(5H) was treated in the same manner as in Example 3. - Got on.
m、p、 149〜151°C
実施例7
d−2−ヒドロキシ−3−(2−アミノフェニルチオ)
−3−(4−メトキンフェニル)プロピオン酸1.27
6g、アセトニトリル121I11ペンタクロロフエニ
lレアセテート2.591g、)リエチルアミン0.4
g及びピリジン0.32gを混合し、5.5時間加熱
還流した。以下実施例3と同様に処理して130gのd
−2−(4−メトキシフェニル)−3−アセトキシ−2
,3−ジヒドロ−1,5−ベンゾチアゼピン−4(5H
)−オンを得た。m, p, 149-151°C Example 7 d-2-hydroxy-3-(2-aminophenylthio)
-3-(4-methquinphenyl)propionic acid 1.27
6g, acetonitrile 121I11pentachlorophenylacetate 2.591g,) ethylamine 0.4
g and 0.32 g of pyridine were mixed and heated under reflux for 5.5 hours. Thereafter, 130 g of d was treated in the same manner as in Example 3.
-2-(4-methoxyphenyl)-3-acetoxy-2
,3-dihydro-1,5-benzothiazepine-4 (5H
)-on was obtained.
m、p、 149〜151’c
実施例8
d−2−ヒドロキシ−3−(2−7ミノフエニルチオ)
−3−(4−メトキシフェニル)プロピオン酸1.27
6 gt DMF 12d1ペンタクロロフェニルアセ
テート2.591g、 トリエチルアミン0.4 g
及びピリジン0.32gを混合し、100’Cで3.5
時間加熱攪拌した。以下実施例3と同様に処理して1.
27gのd−2−(4−メトキシフェニル)−3−7セ
トキシー2.3−ジヒドロ−1,5−ベンゾチアゼピン
−4(5H)−オンを得た。m, p, 149-151'c Example 8 d-2-hydroxy-3-(2-7minophenylthio)
-3-(4-methoxyphenyl)propionic acid 1.27
6 gt DMF 12d1 Pentachlorophenylacetate 2.591g, Triethylamine 0.4g
and 0.32g of pyridine were mixed and heated to 3.5g at 100'C.
The mixture was heated and stirred for hours. The following steps were performed in the same manner as in Example 3.
27 g of d-2-(4-methoxyphenyl)-3-7setoxy-2,3-dihydro-1,5-benzothiazepin-4(5H)-one was obtained.
m、p、 148〜I50°C
実施例9
d−2−ヒドロキシ−3−(2−7ミノフエニルチオ)
−3−(4−メトキシフェニル)プロピオン酸1.27
6g、酢酸2.4−ジニトロフェニルエステル1.8g
及びアセトニトリルl2IE/の懸濁液に、室温攪拌下
、ピリジン0.64gを加え、次いで同温度で3時間榎
拌した。以下実施例3と同様に処理して1.09 gの
d−2−(4−メトキシフェニル)−3−アセトキシ−
2,3−ジヒドロ−1,5−ベンゾチアゼピン−4(5
H)−オンを得た。m, p, 148-I50°C Example 9 d-2-hydroxy-3-(2-7minophenylthio)
-3-(4-methoxyphenyl)propionic acid 1.27
6g, acetic acid 2,4-dinitrophenyl ester 1.8g
0.64 g of pyridine was added to the suspension of acetonitrile l2IE/ while stirring at room temperature, and then stirred at the same temperature for 3 hours. Thereafter, 1.09 g of d-2-(4-methoxyphenyl)-3-acetoxy-
2,3-dihydro-1,5-benzothiazepine-4 (5
H)-one was obtained.
m、p、 144〜147°C 手続補正書(自発)5゜ 昭和59年10月 9日m, p, 144-147°C Procedural amendment (voluntary) 5゜ October 9, 1982
Claims (1)
基を表わす) で示される2−ヒドロキシ−3−(2−アミノフェニル
チオ)−3−フェニルプロピオン酸を塩基の存在下酢酸
の活性エステルと反応させることを特徴とする一般式 ▲数式、化学式、表等があります▼ (式中、Arは前記と同じ基を表わす) で示される1,5−ベンゾチアゼピン誘導体の製造法。[Claims] 2-hydroxy-3-(2-aminophenyl) represented by the general formula ▲ Numerical formulas, chemical formulas, tables, etc. ▼ (In the formula, Ar represents a phenyl group substituted with a lower alkoxy group) General formula characterized by reacting thio)-3-phenylpropionic acid with an active ester of acetic acid in the presence of a base ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, Ar represents the same group as above) A method for producing a 1,5-benzothiazepine derivative represented by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18543484A JPS6165875A (en) | 1984-09-06 | 1984-09-06 | Production of 1,5-benzothiazepine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18543484A JPS6165875A (en) | 1984-09-06 | 1984-09-06 | Production of 1,5-benzothiazepine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6165875A true JPS6165875A (en) | 1986-04-04 |
JPH0573748B2 JPH0573748B2 (en) | 1993-10-15 |
Family
ID=16170717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18543484A Granted JPS6165875A (en) | 1984-09-06 | 1984-09-06 | Production of 1,5-benzothiazepine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6165875A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57136581A (en) * | 1981-02-18 | 1982-08-23 | Nippon Kayaku Co Ltd | Preparation of 1,5-benzothiazepin derivative |
-
1984
- 1984-09-06 JP JP18543484A patent/JPS6165875A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57136581A (en) * | 1981-02-18 | 1982-08-23 | Nippon Kayaku Co Ltd | Preparation of 1,5-benzothiazepin derivative |
Also Published As
Publication number | Publication date |
---|---|
JPH0573748B2 (en) | 1993-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4582918A (en) | Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols | |
US4973750A (en) | Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols | |
CA2006464C (en) | Process for the preparation of phenyl-1 diethylaminocarbonyl-1 phtaliminomethyl-2 cyclopropane 2 | |
US4939295A (en) | Process for the preparation of intermediates for the synthesis of diltiazem | |
CA2468426A1 (en) | Process for preparing n-(4'-cyano-3'-trifluoromethylphenyl)-3-(4"-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide | |
JPS6165875A (en) | Production of 1,5-benzothiazepine derivative | |
EP0196943B1 (en) | 8-thiotetrahydroquinoleine derivatives and their salts | |
JPH0140033B2 (en) | ||
FR2467210A1 (en) | PROCESS FOR THE PREPARATION OF DERIVATIVES OF 1,1-DIOXOPENICILLANIC ACID | |
KR0163770B1 (en) | Process for the production of 3,4-epoxybutyrate and intermediate thereof | |
US4677214A (en) | Intermediates for preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols | |
JP3201998B2 (en) | Method for producing (S) -benzoxazine derivative and method for racemizing (R) -benzoxazine derivative | |
EP0016665B1 (en) | Process for the preparation of xanthone derivatives | |
US4649213A (en) | Process for producing an α-aromatic group substituted alkanoic acid derivative | |
JPS6078973A (en) | Production of 1,5-benzothiazepine derivative | |
JPS6145639B2 (en) | ||
JP3669724B2 (en) | Process for producing optically active 3- (p-alkoxyphenyl) glycidic acid ester derivative | |
US4308383A (en) | N-(3-(1'-3"-Oxapentamethyleneamino-ethylideneamino)-2,4,6-triiodobenzoyl)-β-amino-α-methylpropionitrile | |
JPS60146884A (en) | Production of 1,5-benzothiazepine derivative | |
JPS6152150B2 (en) | ||
JP3669726B2 (en) | Process for producing optically active 3- (p-alkoxyphenyl) glycidic acid ester derivative | |
KR860000671B1 (en) | Process for preparing piperazinyl derivatives of quinoline carboxylic acid | |
JP3538889B2 (en) | Method for producing alkylthioacetamide | |
JPS59231065A (en) | Novel propionic acid derivative salt and optical resolution of propionic acid derivative | |
JPS60155168A (en) | Production of 1,5-benzothiazepine derivative |